Stay updated on CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry, v3.6.5, appears in the study history, replacing the previous v3.6.4. This reflects an update to the page metadata on the ClinicalTrials.gov record.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.6.4 is now shown as the latest version, replacing the previous v3.6.3. This indicates a software update to the ClinicalTrials.gov interface rather than a change to the study data.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe record history shows a revision bump from v3.6.2 to v3.6.3, indicating a minor update to the page's documentation.SummaryDifference0.1%

- Check44 days agoChange DetectedThe record history now includes a new revision entry for v3.6.2 and removes the previous v3.6.0 entry, reflecting an update to the page's version-tracking information.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history now includes a Last verified timestamp and a Last known status was field, and the revision is shown as v3.6.0, replacing v3.5.5. These updates add metadata for verification and status tracking without altering the underlying study information.SummaryDifference3%

- Check65 days agoChange DetectedThe record history adds revision v3.5.5 and removes revision v3.5.4, indicating the page was updated to the latest revision.SummaryDifference0.1%

Stay in the know with updates to CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.